Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
matriks/Shikari® (Q-ADA) Adalimumab ELISA/ADA-FD-HUM188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

matriks/Shikari® (Q-ADA) Adalimumab ELISA/ADA-FD-HUM

Enzyme immunoassay for the quantitative determination of Adalimumab (Humira®) in serum and plasma.

This kit has been especially developed for the quantitative determination of adalimumab in serum and plasma samples between the Cmin and Cmax range of concentrations.

Adalimumab Drug Bank Accession Number is DB00051 

Adalimumab is a monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn"s disease, and ankylosing spondylitis. Adalimumab binds with specificity to tumor necrosis factor-alpha (TNF-alpha) and inhibits its interaction with the p55 and p75 cell surface TNF receptors.

Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.

All SHIKARI® ELISA kits are suitable for biosimilar work.

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

For technical inquiry, please contact techsupport@matriksbiotek.com

 

新闻动态
行业前沿
技术文章
最新产品